Cubist Systematic Strategies’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-319,296
| Closed | -$13M | – | 3398 |
|
|
2024
Q1 | $13M | Buy |
319,296
+146,817
| +85% | +$5.5M | 0.07% | 358 |
|
|
2023
Q4 | $6.37M | Sell |
172,479
-20,041
| -10% | -$755K | 0.04% | 720 |
|
|
2023
Q3 | $7.35M | Buy |
192,520
+151,415
| +368% | +$6.2M | 0.05% | 534 |
|
|
2023
Q2 | $1.48M | Buy |
41,105
+34,487
| +521% | +$1.18M | 0.01% | 1717 |
|
|
2023
Q1 | $253K | Sell |
6,618
-38,930
| -85% | -$1.83M | ﹤0.01% | 3085 |
|
|
2022
Q4 | $2.59M | Buy |
45,548
+45,539
| +505,989% | +$2.33M | 0.02% | 1626 |
|
|
2022
Q3 | $0 | Sell |
9
-202,346
| -100% | -$8.94M | ﹤0.01% | 4538 |
|
|
2022
Q2 | $8.9M | Buy |
202,355
+160,175
| +380% | +$6.93M | 0.05% | 522 |
|
|
2022
Q1 | $1.68M | Buy |
42,180
+26,549
| +170% | +$946K | 0.01% | 1621 |
|
|
2021
Q4 | $629K | Sell |
15,631
-58,588
| -79% | -$2.19M | 0.01% | 2279 |
|
|
2021
Q3 | $3.02M | Sell |
74,219
-51,423
| -41% | -$2.15M | 0.04% | 750 |
|
|
2021
Q2 | $5.71M | Buy |
125,642
+41,614
| +50% | +$1.84M | 0.06% | 459 |
|
|
2021
Q1 | $3.5M | Sell |
84,028
-70,744
| -46% | -$3.23M | 0.04% | 648 |
|
|
2020
Q4 | $6.61M | Buy |
154,772
+96,546
| +166% | +$3.47M | 0.09% | 309 |
|
|
2020
Q3 | $1.53M | Sell |
58,226
-72,146
| -55% | -$2.01M | 0.02% | 1070 |
|
|
2020
Q2 | $3.5M | Buy |
130,372
+65,752
| +102% | +$1.48M | 0.06% | 507 |
|
|
2020
Q1 | $1.16M | Sell |
64,620
-194,936
| -75% | -$3.7M | 0.03% | 741 |
|
|
2019
Q4 | $4.6M | Buy |
259,556
+244,185
| +1,589% | +$4.23M | 0.08% | 340 |
|
|
2019
Q3 | $238K | Sell |
15,371
-18,909
| -55% | -$311K | ﹤0.01% | 1680 |
|
|
2019
Q2 | $589K | Buy |
34,280
+22,729
| +197% | +$367K | 0.01% | 1376 |
|
|
2019
Q1 | $186K | Buy |
+11,551
| New | +$187K | 0.01% | 1822 |
|
|
2018
Q4 | – | Sell |
-15,018
| Closed | -$273K | – | 2154 |
|
|
2018
Q3 | $273K | Sell |
15,018
-7,328
| -33% | -$128K | 0.01% | 1225 |
|
|
2018
Q2 | $377K | Buy |
22,346
+9,134
| +69% | +$173K | 0.02% | 943 |
|
|
2018
Q1 | $259K | Sell |
13,212
-13,078
| -50% | -$253K | 0.02% | 1246 |
|
|
2017
Q4 | $533K | Buy |
26,290
+13,952
| +113% | +$256K | 0.03% | 860 |
|
|
2017
Q3 | $214K | Sell |
12,338
-29,883
| -71% | -$405K | 0.01% | 1406 |
|
|
2017
Q2 | $541K | Buy |
+42,221
| New | +$564K | 0.03% | 702 |
|
|
2017
Q1 | – | Sell |
-15,500
| Closed | -$153K | – | 1713 |
|
|
2016
Q4 | $153K | Sell |
15,500
-3,781
| -20% | -$41.4K | 0.01% | 1364 |
|
|
2016
Q3 | $233K | Sell |
19,281
-12,593
| -40% | -$129K | 0.02% | 1164 |
|
|
2016
Q2 | $275K | Buy |
+31,874
| New | +$315K | 0.02% | 1134 |
|
|
2015
Q4 | – | Sell |
-27,947
| Closed | -$375K | – | 1826 |
|
|
2015
Q3 | $375K | Buy |
+27,947
| New | +$561K | 0.02% | 1118 |
|
|
2015
Q1 | – | Sell |
-18,355
| Closed | -$177K | – | 1963 |
|
|
2014
Q4 | $177K | Buy |
+18,355
| New | +$163K | 0.01% | 1559 |
|
Other funds holding HALO
SCM
Cubist Systematic Strategies's HALO Position: Q2 2024 in Review
Cubist Systematic Strategies sold out of Halozyme (HALO) in Q2 2024, closing a stake of 319,296 shares — an estimated $13M sold.
Cubist Systematic Strategies first reported a position in HALO in Q4 2014 and held it in 32 quarters. The position peaked at $13M in Q1 2024. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.
- Cubist Systematic Strategies reported no remaining Halozyme position as of Q2 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 319,296 Halozyme shares in Q2 2024, an estimated $13M.
- Cubist Systematic Strategies first reported a position in Halozyme in Q4 2014 and held it in 32 quarters.
- Cubist Systematic Strategies's Halozyme position peaked at $13M in Q1 2024.
- 460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.
Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.